Intelligence
Latest
Intel
Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by private investment giant Blackstone’s Life Sciences division, in a deal worth up to $3.1bn, according to a report by Reuters.
Intel
TOP STORY: SolarWinds has agreed to be taken private by buyout firm Turn/River Capital in a $4.4bn deal that marks the latest indication of a potential rebound in debt-funded acquisitions as borrowing costs ease, according to a report by Reuters.
Intel
Mitsubishi Chemical has agreed to sell its pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, to US private equity firm Bain Capital in a deal valued at JPY510bn ($3.36bn) as part of a broader effort to streamline its portfolio.
Intel
The total market value of private equity assets hit a new global high of $10.8tn at the end of 2024, increasing by 11.6% since 2023, according to new analysis from Ocorian, a specialist in fund administration, capital markets, corporate, and fiduciary services.
Intel
Insignia Financial, Australia’s third-largest superannuation player, has attracted a third suitor, with Brookfield Asset Management entering the fray to acquire the money manager with an AUD3bn ($1.9bn) offer, according to a report by Reuters.
Intel
US private equity giant KKR has increased its offer price for Japanese IT company Fuji Soft to JPY9,850 per share, surpassing a competing bid from rival buyout firm Bain Capital in an intensifying takeover battle, according to a report by Reuters.
Intel
Private equity firms Warburg Pincus and Berkshire Partners have agrered to acquire aircraft parts manufacturer Triumph Group in a take private deal valued at approximately $3bn, including debt, according to a reports.
Intel
Blackstone has reported stronger-than-expected earnings for the fourth quarter of last year, fuelled by a resurgence in dealmaking and early signs of stabilisation in the troubled commercial real estate sector, according to a report by Reuters.
Intel
Private equity giant KKR has taken a 12% stake in Henry Schein and reached an agreement to add independent directors to the company’s board, the medical and dental supplies distributor announced Wednesday, according to a report by the Wall Street Journal.
Intel
Bain Capital Private Equity has submitted a proposal to acquire the remaining 61% of shares in Surgery Partners that it does not already own, at $25.75 per share, giving the surgical facility operator a value of $3.2bn, according to a report by Reuters.
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
